Abstract
Objective
The objective of this study was to evaluate the genetic profiles of selected cytokines (transforming growth factor beta 1, tumor necrosis factor alpha, interleukin-6, interferon gamma, and interleukin-10) in systemic lupus erythematosus and the contributions of human leukocyte antigen (HLA)-DRB1 and -DQB1 alleles to susceptibility for this disease.
Patients and methods
The study was carried out in 24 SLE patients and 36 healthy controls (from Upper Silesia) using polymerase chain reaction methods. All persons were of Caucasoid origin. Standard association analysis was used to compare the HLA alleles and frequency of cytokine gene polymorphisms between these groups.
Results
Only the frequency of HLA-DRB1*07 allele was higher in SLE patients than controls (odds ratio 2.92, 95% confidence interval 1.16–7.33), but the difference did not reach statistical significance when Bonferroni’s adjustment procedure was performed. No other significant associations were noted between class II alleles (DR1-DR6, DR8-DR10, DQ1-DQ4) and SLE. The frequency of the interleukin-6 GG and GC genotypes was significantly higher in SLE patients than in controls, and a significantly higher percentage of the G vs C alleles between patients and controls was revealed (odds ratio 2.53, 95% confidence interval 1.37–4.65, chi-squared test 8.16, P<0.05). The most significant association of increased frequency of the G allele with SLE was more commonly noted in HLA-DRB1*07-positive patients (odds ratio 10.29, 95% confidence interval 5.34–19.83, P<0.001). These data indicate that this combination could contribute toward determining the susceptibility to SLE, but its possible significance will require confirmation by further studies.
Similar content being viewed by others
References
Lindqvist AKB, Alarcón-Riquelme ME (1999) The genetics of systemic lupus erythematosus. Scand J Immunol 50:562–571
Alcocer-Varela J, Iglesias A, Llorente L, Alarcon-Segovia D (1985) Effects of L-canavanine on T cells may explain the induction of systemic lupus erythematosus by alfalfa. Arthritis Rheum 28:52–57
Tsao BP (2002) An update on genetic studies of systemic lupus erythematosus. Curr Rheumatol Rep 4:359–367
Tan FK, Arnett FC (1998) The genetics of lupus. Curr Opin Rheumatol 7:399–408
Tsao BP (1998) Genetic susceptibility to lupus nephritis. Lupus 8:585–590
Wakeland EK, Liu K, Graham RR, Behrens TW (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity 15:397–408
Davies EJ, Steers G, Ollier WER, Grennan DM, Cooper RG, Hay EM, Hillarby MC (1995) Relative contributions of HLA-DQA and complement C4A loci in determining susceptibility to systemic lupus erythematosus. Br J Rheumatol 34:221–225
Sullivan KE (2000) Genetics of systemic lupus erythematosus. Rheum Dis Clin North Am 26:229–256
Gladman DD, Urowitz MB, Darlington GA (1999) Disease expression and class II HLA antigens in systemic lupus erythematosus. Lupus 8:466–470
Schotte H, Willeke P, Rust S, Assmann G, Domschke W, Gaubitz M, Schluter B (2003) The transforming growth factor-beta1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus. Lupus 12:86–92
Walker SE, McMurray RW, Houri JM, Allen SH, Keisler D, Sharp GC, Schlechte JA (1998) Effects of prolactin in stimulating disease activity in systemic lupus erythematosus. Ann N Y Acad Sci 840:762–772
Hrycek A, Cieślik P, Tustanowski J, Nowak S, Jedynak P (2001) Selected serum cytokines in systemic lupus erythematosus treated with quinagolide. Lupus 10:424–430
Wilder RI (1998) Hormones, pregnancy and autoimmune diseases. Ann N Y Acad Sci 840:45–50
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Olerup O, Zetterquist H (1992) HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 h: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39:225–235
Gardner MJ, Altman DG (1989) Statistics with confidence. British Medical Journal Books, London
Hochberg Y, Tamhane AC (1987) Multiple comparison procedures. Wiley and Sons, New York
Millard TP, Kondeatis E, Vaughan RW, Lewis CM, Khamashta MA, Hughes GRV, Hawk JLM, McGregor JM (2001) Polymorphic light eruption and the HLA DRB1*0301 extended haplotype are independent risk factors for cutaneous lupus erythematosus. Lupus 10:473–479
Schur PH (1995) Genetics of systemic lupus erythematosus. Lupus 4:425–437
Davas EM, Tsirogianni A, Kappou I, Karamitsos D, Economidou I, Dantis PC (1999) Serum IL-6, TNF alpha, p 75 sr TNF alpha, sr IL-2 alpha levels and disease activity in systemic lupus erythematosus. Clin Rheumatol 18:17–22
Linker-Israeli M, Deanes RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinkenberg JR ( 1991) Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 147:117–123
Jara LJ, Irigoyen L, Ortiz MJ, Zazueta B, Bravo G, Espinoza L R (1998) Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus. Clin Rheumatol 17:110–114
Park YB, Lee SK, Kim DS, Lee J, Lee CH, Song CH (1998) Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp. Rheumatol 16:283–288
Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WER, Hutchinson IV (1997) Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J. Rheumatol 24:2314–2317
Gonzalez-Gay MA, Hajeer AH, Dababneh A, Garcia-Porrua C, Mattey DL, Amoli MM, Thomson W, Ollier WER ( 2002) IL-6 promoter polymorphism at position-174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis. Clin Exp Rheumatol 20:179–184
Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369–1376
Youinou P, Le Corre R (1999) The multi-faceted role of transforming growth factor-beta in systemic lupus erythematosus. Lupus 8:87–88
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hrycek, A., Siekiera, U., Cieślik, P. et al. HLA-DRB1 and -DQB1 alleles and gene polymorphisms of selected cytokines in systemic lupus erythematosus. Rheumatol Int 26, 1–6 (2005). https://doi.org/10.1007/s00296-004-0503-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-004-0503-8